The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change

被引:40
作者
Rehm, Heidi L. [1 ,2 ,3 ,34 ]
Alaimo, Joseph T. [4 ,5 ,6 ]
Aradhya, Swaroop [7 ,8 ]
Bayrak-Toydemir, Pinar [9 ,10 ]
Best, Hunter [9 ,10 ]
Brandon, Rhonda [11 ]
Buchan, Jillian G. [12 ]
Chao, Elizabeth C. [13 ]
Chen, Elaine [7 ]
Clifford, Jacob [13 ]
Cohen, Ana S. A. [4 ,5 ,6 ]
Conlin, Laura K. [14 ,15 ]
Das, Soma [16 ]
Davis, Kyle W. [17 ]
del Gaudio, Daniela [16 ]
Del Viso, Florencia [4 ]
Divincenzo, Christina [18 ]
Eisenberg, Marcia [19 ]
Guidugli, Lucia [20 ]
Hammer, Monia B. [20 ]
Harrison, Steven M. [13 ]
Hatchell, Kathryn E. [7 ]
Dyer, Lindsay Havens [11 ]
Hoang, Lily U. [13 ]
Holt, James M. [21 ]
Jobanputra, Vaidehi [22 ,23 ]
Karbassi, Izabela D. [18 ]
Kearney, Hutton M. [24 ]
Kelly, Melissa A. [21 ]
Kelly, Jacob M. [21 ]
Kluge, Michelle L. [24 ]
Komala, Timothy
Kruszka, Paul [11 ]
Lau, Lynette [25 ]
Lebo, Matthew S. [3 ,26 ]
Marshall, Christian R. [25 ,27 ]
Mcknight, Dianalee [7 ]
Mcwalter, Kirsty [11 ]
Meng, Yan [28 ]
Nagan, Narasimhan [29 ]
Neckelmann, Christian S. [28 ]
Neerman, Nir [17 ]
Niu, Zhiyv [24 ]
Paolillo, Vitoria K. [4 ]
Paolucci, Sarah A. [12 ]
Perry, Denise [30 ]
Pesaran, Tina
Radtke, Kelly [11 ,13 ]
Rasmussen, Kristen J.
Retterer, Kyle
机构
[1] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA
[2] Broad Inst MIT & Harvard, Med & Populat Genet, Cambridge, MA USA
[3] Harvard Med Sch, Pathol, Boston, MA USA
[4] Childrens Mercy Hosp, Dept Pathol & Lab Med, Kansas City, MO USA
[5] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO USA
[6] Childrens Mercy Hosp, Genom Med Ctr, Kansas City, MO USA
[7] Invitae, San Francisco, CA USA
[8] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA USA
[9] ARUP Labs, Salt Lake City, UT USA
[10] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA
[11] GeneDx LLC, Gaithersburg, MD USA
[12] Univ Washington, Genet Div, Lab Med & Pathol, Seattle, WA USA
[13] Ambry Genet, Aliso Viejo, CA USA
[14] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA USA
[15] Univ Penn, Pathol & Lab Med, Philadelphia, PA USA
[16] Univ Chicago, Human Genet, Chicago, IL USA
[17] Variantyx, Framingham, MA USA
[18] Quest Diagnost, Marlborough, MA USA
[19] Labcorp, Womens Hlth & Genet, Res Triangle Pk, NC USA
[20] Rady Childrens Inst Genom Med, San Diego, CA USA
[21] HudsonAlpha Clin Serv Lab LLC, Huntsville, AL USA
[22] New York Genome Ctr, Mol Diagnost, New York, NY USA
[23] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA
[24] Mayo Clin, Dept Lab Med & Pathol, Div Lab Genet & Genom, Rochester, MN USA
[25] Hosp Sick Children, Dept Paediat Lab Med, Div Genome Diagnost, Toronto, ON, Canada
[26] Mass Gen Brigham, Lab Mol Med, Cambridge, MA USA
[27] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[28] Fulgent Genet, Temple City, CA USA
[29] Labcorp, Womens Hlth & Genet, Westborough, MA USA
[30] Illumina Inc, San Diego, CA USA
[31] Univ Missouri, Sch Med, Dept Pediat & Pathol, Kansas City, MO USA
[32] Stanford Med, Dept Pathol, Palo Alto, CA USA
[33] Hosp Sick Children, Clin & Metab Genet, Toronto, ON, Canada
[34] Massachusetts Gen Hosp, Ctr Genom Med, Simches Res Bldg, CPZN 5 812, 185 Cambridge St, Boston, MA 02114 USA
关键词
Laboratory reporting methods; Multi-gene panels; Variants of uncertain significance; VUS; VARIANTS;
D O I
10.1016/j.gim.2023.100947
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Variants of uncertain significance (VUS) are a common result of diagnostic genetic testing and can be difficult to manage with potential misinterpretation and downstream costs, including time investment by clinicians. We investigated the rate of VUS reported on diagnostic testing via multi-gene panels (MGPs) and exome and genome sequencing (ES/GS) to measure the magnitude of uncertain results and explore ways to reduce their potentially detrimental impact.Methods: Rates of inconclusive results due to VUS were collected from over 1.5 million sequencing test results from 19 clinical laboratories in North America from 2020 to 2021. Results: We found a lower rate of inconclusive test results due to VUSs from ES/GS (22.5%) compared with MGPs (32.6%; P < .0001). For MGPs, the rate of inconclusive results correlated with panel size. The use of trios reduced inconclusive rates (18.9% vs 27.6%; P < .0001), whereas the use of GS compared with ES had no impact (22.2% vs 22.6%; P = ns).Conclusion: The high rate of VUS observed in diagnostic MGP testing warrants examining current variant reporting practices. We propose several approaches to reduce reported VUS rates, while directing clinician resources toward important VUS follow-up. (c) 2023 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页数:8
相关论文
共 12 条
  • [1] Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress
    Culver, J. O.
    Brinkerhoff, C. D.
    Clague, J.
    Yang, K.
    Singh, K. E.
    Sand, S. R.
    Weitzel, J. N.
    [J]. CLINICAL GENETICS, 2013, 84 (05) : 464 - 472
  • [2] Experiences of individuals with a variant of uncertain significance on genetic testing for hereditary cancer risks: a mixed method systematic review
    Gould, Danielle
    Walker, Rachel
    Makari-Judson, Grace
    Seven, Memnun
    [J]. JOURNAL OF COMMUNITY GENETICS, 2022, 13 (04) : 371 - 379
  • [3] Variant interpretation using population databases: Lessons from gnomAD
    Gudmundsson, Sanna
    Singer-Berk, Moriel
    Watts, Nicholas A.
    Phu, William
    Goodrich, Julia K.
    Solomonson, Matthew
    Rehm, Heidi L.
    MacArthur, Daniel G.
    O'Donnell-Luria, Anne
    [J]. HUMAN MUTATION, 2022, 43 (08) : 1012 - 1030
  • [4] Improved provider preparedness through an 8-part genetics and genomic education program
    Hajek, Catherine
    Hutchinson, Allison M.
    Galbraith, Lauren N.
    Green, Robert C.
    Murray, Michael F.
    Petry, Natasha
    Preys, Charlene L.
    Zawatsky, Carrie L. B.
    Zoltick, Emilie S.
    Christensen, Kurt D.
    [J]. GENETICS IN MEDICINE, 2022, 24 (01) : 214 - 224
  • [5] A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders
    Karbassi, Izabela
    Maston, Glenn A.
    Love, Angela
    DiVincenzo, Christina
    Braastad, Corey D.
    Elzinga, Christopher D.
    Bright, Alison R.
    Previte, Domenic
    Zhang, Ke
    Rowland, Charles M.
    McCarthy, Michele
    Lapierre, Jennifer L.
    Dubois, Felicita
    Medeiros, Katelyn A.
    Batish, Sat Dev
    Jones, Jeffrey
    Liaquat, Khalida
    Hoffman, Carol A.
    Jaremko, Malgorzata
    Wang, Zhenyuan
    Sun, Weimin
    Buller-Burckle, Arlene
    Strom, Charles M.
    Keiles, Steven B.
    Higgins, Joseph J.
    [J]. HUMAN MUTATION, 2016, 37 (01) : 127 - 134
  • [6] Genetic Counselor Review of Genetic Test Orders in a Reference Laboratory Reduces Unnecessary Testing
    Miller, Christine E.
    Krautscheid, Patti
    Baldwin, Erin E.
    Tvrdik, Tatiana
    Openshaw, Amanda S.
    Hart, Kim
    LaGrave, Danielle
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (05) : 1094 - 1101
  • [7] An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases
    Owen, Mallory J.
    Lefebvre, Sebastien
    Hansen, Christian
    Kunard, Chris M.
    Dimmock, David P.
    Smith, Laurie D.
    Scharer, Gunter
    Mardach, Rebecca
    Willis, Mary J.
    Feigenbaum, Annette
    Niemi, Anna-Kaisa
    Ding, Yan
    Van der Kraan, Luca
    Ellsworth, Katarzyna
    Guidugli, Lucia
    Lajoie, Bryan R.
    McPhail, Timothy K.
    Mehtalia, Shyamal S.
    Chau, Kevin K.
    Kwon, Yong H.
    Zhu, Zhanyang
    Batalov, Sergey
    Chowdhury, Shimul
    Rego, Seema
    Perry, James
    Speziale, Mark
    Nespeca, Mark
    Wright, Meredith S.
    Reese, Martin G.
    De la Vega, Francisco M.
    Azure, Joe
    Frise, Erwin
    Rigby, Charlene Son
    White, Sandy
    Hobbs, Charlotte A.
    Gilmer, Sheldon
    Knight, Gail
    Oriol, Albert
    Lenberg, Jerica
    Nahas, Shareef A.
    Perofsky, Kate
    Kim, Kyu
    Carroll, Jeanne
    Coufal, Nicole G.
    Sanford, Erica
    Wigby, Kristen
    Weir, Jacqueline
    Thomson, Vicki S.
    Fraser, Louise
    Lazare, Seka S.
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [8] Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
    Richards, Sue
    Aziz, Nazneen
    Bale, Sherri
    Bick, David
    Das, Soma
    Gastier-Foster, Julie
    Grody, Wayne W.
    Hegde, Madhuri
    Lyon, Elaine
    Spector, Elaine
    Voelkerding, Karl
    Rehm, Heidi L.
    [J]. GENETICS IN MEDICINE, 2015, 17 (05) : 405 - 424
  • [9] "Possibly positive or certainly uncertain?": participants' responses to uncertain diagnostic results from exome sequencing
    Skinner, Debra
    Roche, Myra I.
    Weck, Karen E.
    Raspberry, Kelly A.
    Foreman, A. Katherine M.
    Strande, Natasha T.
    Berg, Jonathan S.
    Evans, James P.
    Henderson, Gail E.
    [J]. GENETICS IN MEDICINE, 2018, 20 (03) : 313 - 319
  • [10] Deep Phenotyping on Electronic Health Records Facilitates Genetic Diagnosis by Clinical Exomes
    Son, Jung Hoon
    Xie, Gangcai
    Yuan, Chi
    Ena, Lyudmila
    Li, Ziran
    Goldstein, Andrew
    Huang, Lulin
    Wang, Liwei
    Shen, Feichen
    Liu, Hongfang
    Mehl, Karla
    Groopman, Emily E.
    Marasa, Maddalena
    Kiryluk, Krzysztof
    Gharavi, Ali G.
    Chung, Wendy K.
    Hripcsak, George
    Friedman, Carol
    Weng, Chunhua
    Wang, Kai
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 103 (01) : 58 - 73